ACTL6A (actin like 6A)

2011-06-01  

Identity

HGNC
LOCATION
3q26.33
LOCUSID
ALIAS
ACTL6,ARPN-BETA,Arp4,BAF53A,INO80K
FUSION GENES

Other Information

Locus ID:

NCBI: 86
MIM: 604958
HGNC: 24124
Ensembl: ENSG00000136518

Variants:

dbSNP: 86
ClinVar: 86
TCGA: ENSG00000136518
COSMIC: ACTL6A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000136518ENST00000392662O96019
ENSG00000136518ENST00000429709O96019
ENSG00000136518ENST00000450518O96019
ENSG00000136518ENST00000487978H7C5S0
ENSG00000136518ENST00000490364C9JQT2

Expression (GTEx)

0
10
20
30
40
50
60
70
80

Pathways

PathwaySourceExternal ID
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
DNA RepairREACTOMER-HSA-73894
Chromatin organizationREACTOMER-HSA-4839726
Chromatin modifying enzymesREACTOMER-HSA-3247509
HATs acetylate histonesREACTOMER-HSA-3214847
RMTs methylate histone argininesREACTOMER-HSA-3214858
Nucleotide Excision RepairREACTOMER-HSA-5696398
Global Genome Nucleotide Excision Repair (GG-NER)REACTOMER-HSA-5696399
DNA Damage Recognition in GG-NERREACTOMER-HSA-5696394
DeubiquitinationREACTOMER-HSA-5688426
UCH proteinasesREACTOMER-HSA-5689603

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
385234072024High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression.0
385234072024High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression.0
366310072023Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.3
367683492023Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer.4
366310072023Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.3
367683492023Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer.4
348982772022DNA Damage Triggers the Nuclear Accumulation of RASSF6 Tumor Suppressor Protein via CDK9 and BAF53 To Regulate p53 Target Gene Transcription.0
351829412022ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.2
365266222022BAF53A drives colorectal cancer development by regulating DUSP5-mediated ERK phosphorylation.4
348982772022DNA Damage Triggers the Nuclear Accumulation of RASSF6 Tumor Suppressor Protein via CDK9 and BAF53 To Regulate p53 Target Gene Transcription.0
351829412022ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.2
365266222022BAF53A drives colorectal cancer development by regulating DUSP5-mediated ERK phosphorylation.4
334082512021ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.28
338963142021ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.2
346876032021Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.14

Citation

Dessen P

ACTL6A (actin like 6A)

Atlas Genet Cytogenet Oncol Haematol. 2011-06-01

Online version: http://atlasgeneticsoncology.org/gene/52255/css/favicon/js/_common.js